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Available online 5 August 2017A human iPSC line was generated from ﬁbroblasts of a patient affected with autosomal dominant Retinitis
Pigmentosa (RP) carrying the mutation p.Gly56Arg in the NR2E3 gene. The transgene-free iPSCs were generated
with the human OSKM transcription factors using the Sendai-virus reprogramming system. iPSCs contained the
expected c.166GNA substitution in exon 2 of NR2E3, expressed the expected pluripotency markers, displayed in
vivo differentiation potential to the three germ layers and had normal karyotype. This cellularmodel will provide
a powerful tool to study the pathogenesis of NR2E3-associated RP.
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Institution Institut de la Vision
Contact information of distributor Olivier Goureau, olivier.goureau@inserm.fr
Type of cell line iPSC
Origin Human
Additional origin info Age: 49-year old
Sex: femaleResource utility
This NR2E3-86-iPS cell line constitutes a unique tool to study the
pathogenesis ofNR2E3-associated Retinitis Pigmentosa (RP); essentially
by generating photoreceptor cells carrying the mutation in order to de-
termine pathogenic mechanism underlying RP caused by mutation in
this photoreceptor-speciﬁc gene.Cell Source Dermal ﬁbroblasts
Method of reprogramming Transgene free (Sendai Virus)
Associated disease Retinitis Pigmentosa (RP)
Gene/locus NR2E3 (c.166GNA; p.Gly56Arg)
Method of modiﬁcation N/A
Gene correction NO
Name of transgene of resistance N/A
Inducible/constitutive system N/A
Date archived/stock date Dec. 22, 2016
Cell line repository/bank Not applicable
Ethical approval Approval by French regulatory agencies:
CPP Ile de France (2012-A01333-40; P12-02)
and the ANSM (B121362-32)Resource details
NR2E3 (Nuclear Receptor subfamily 2 group Emember 3) is a mem-
ber of the nuclear hormone receptor superfamily of ligand-activated
transcription factors, whose expression is restricted to photoreceptors
and essential for proper rod and cone photoreceptor differentiation
(Mollema and Haider 2010). Most of the disorders linked to mutations
in this gene have a recessive mode of inheritance and lead to enhanced
S-cone sensitivity syndrome, including Goldmann-Favre syndrome
(Schorderet and Escher 2009). Only one mutation (p.Gly56Arg) in the
ﬁrst zinc-ﬁnger of the DNA-binding domain of NR2E3 causes autosomal
dominant Retinitis Pigmentosa (RP)with a relatively high prevalence (3
to 3.5%) in Europe (Audo et al. 2012).
In this study, skin ﬁbroblasts from a 49-year-old woman were
reprogrammed into iPSCs using non-integrative Sendai virusesan open access article undercontaining the reprogramming factors, OCT3/4, SOX2, CMYC, KLF4.
The presence of the mutation (c.166GNA p.Gly56Arg) in the derived
NR2E3-86 iPS cell line was conﬁrmed by Sanger sequencing (Fig. 1A).
NR2E3-86 iPS cell colonies displayed a typical ES-like colonymorpholo-
gy and growth behavior and they stained positive for alkaline phospha-
tase activity (Fig. 1B).We conﬁrmed the clearance of the vectors and thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
2 A. Terray et al. / Stem Cell Research 24 (2017) 1–4exogenous reprogramming factor genes by qPCR after ten passages (Fig.
1C). Immunoﬂuorescence analysis revealed expression of transcription
factors OCT4 and NANOG, and surface markers SSEA4 and TRA1-60,
characteristics of pluripotent stem cells (Fig. 1D-E). Flow cytometryFig. 1. Characterization of theconﬁrmed the expression of the pluripotent markers SSEA4 and TRA1-
81 (Supplementary Fig. 1A). The endogenous expression of the
pluripotency associated transcription factors DNMT3B, LIN28A, NANOG,
NODAL, POU5F1 (OCT4), TERT and GDF3 evaluated by RT-qPCR wasNR2E3-86-iPS cell line.
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The NR2E3-86 iPS cell line displayed a normal karyotype (46, XX)
after more than twenty culture passages (Fig. 1G). The identity of the
iPS cell line with parental ﬁbroblasts and genomic integrity was con-
ﬁrmed by SNP genotyping (Supplementary Fig. 1B). Teratoma assays
showed the presence of normal differentiation towards endodermal, ec-
todermal and mesodermal layers (Fig. 1H). NR2E3-86 iPS cell line was
negative for Mycoplasma contamination (Supplementary Fig. 1C).
Taken together, we have successfully reprogrammed p.Gly56Arg
NR2E3 dermal ﬁbroblasts into iPSCs that can be used to generate photo-
receptors in order to study pathogenic mechanism underlying RP
caused by mutation in the NR2E3 gene (Table 1).Materials and methods
Human ﬁbroblast cultures and reprogramming
Small pieces of punch biopsy placed into a T25 cm2 culture dishwere
exposed to aminimal amount ofmedia Dulbecco'sModiﬁed Eagle'sme-
dium (DMEM) with 10% fetal calf serum (FCS), 1 mM sodium pyruvate,
Amphotericin β (Fungizone®) and penicillin–streptomycin (all from
ThermoFischer Scientiﬁc), and incubated at 37 °C in 5% CO2 in a humid-
iﬁed incubator. The following day, 2 ml of fresh medium was added.
When sufﬁcient ﬁbroblast outgrowth had occurred, cells were washed
in PBS, dissociated using TrypLE Express (Thermo Fischer Scientiﬁc)
and re-plated at a split ratio of 1:3. Human ﬁbroblasts at 50–80% of con-
ﬂuence were transduced using the CytoTune Sendai reprogramming
vectors Oct4, Klf4, Sox2 and c-Myc (ThermoFischer Scientiﬁc) and cul-
tured for 6 days inﬁbroblastmediumbefore to be plate onmitomycined
human foreskin (MHF)-seeded dishes. The day after, the ﬁbroblast me-
dium was replaced with the iPS medium, corresponding to ReproStem
medium (ReproCELL, Ozyme) supplemented with 10 ng/ml of human
recombinant FGF2 (PreproTech France). The emergent hiPSC colonies
were picked under a stereomicroscope according to their hESC-like col-
ony morphology and expanded on feeder layers. After generation of a
frozen stocks, hiPSCs were cultured on MHF feeder layers or preferen-
tially adapted and cultured in feeder free conditions (Reichman et al.
2017) on truncated recombinant human vitronectin-coated dishes
with Essential 8™ medium (both from ThermoFischer Scientiﬁc). Ab-
sence of mycoplasma contamination was veriﬁed by the MycoAlert™
Mycoplasma Detection Kit (selective biochemical test of mycoplasma
enzymes) according to the manufacturer's instructions (Lonza).
After ten passages, the clearance of the exogenous reprogramming
factors and Sendai virus genome was conﬁrmed by qPCR following the
manufacturer's instructions (ThermoFischer Scientiﬁc) (Table 2).Table 1
Characterization and validation.
Classiﬁcation Test
Morphology Photography
AP staining
Phenotype qPCR
Immunohistochemistry
Flow cytometry
Genotype Karyotype (G-banding) and resolution
SNP array analysis
Identity SNP array analysis
Mutation analysis (IF APPLICABLE) Sequencing
Microbiology and virology Mycoplasma
Differentiation potential Teratoma formation
Donor screening (OPTIONAL) N/A
Genotype additional (OPTIONAL) N/AMutation analysis
Genomic DNA from hiPSCs was extractedwith Nucleospin Tissue Kit
(Macherey-Nagel) according to the manufacturer instruction. PCR am-
pliﬁcation ﬂanking exon 2 of NR2E3 gene (Table 2) was performed
using HOT FIRE Pol DNA Polymerase (Solis BioDyne). PCR products
were sequenced using BigDye® Terminator v1.1 Cycle Sequencing Kit
(ThermoFischer Scientiﬁc) on a 3730 DNA analyzer (Applied
Biosystems).
Karyotype analyses
Conventional cytogenetic analysis was performed as described pre-
viously (Reichman et al. 2014). Molecular karyotype was analyzed by
SNP genotyping using Illumina's Inﬁnium HumanCore-24 Bead Chips
(Illumina, Inc., San Diego, USA) at Integragen (Evry, France). Processing
was performed on genomic DNA following the manufacturer's proce-
dures. LogR ratio and B allele plots were generated in GenomeStudio
software (Illumina, Inc.).
In vivo pluripotency analysis by teratoma formation assay
Teratoma assays were performed as described previously
(Reichman et al. 2014).
Real-Time PCR analysis
Total RNAs were extracted using Nucleospin RNA II kit (Macherey-
Nagel) and cDNA synthesized using the QuantiTect reverse transcription
kit (Qiagen) following manufacturer's recommendations. qPCR analysis
was performed in three minimum independent biological experiments
with custom TaqMan® Array 96-Well Fast plates (Thermo Fischer
Scientiﬁc) according to the manufacturer's protocol as described previ-
ously (Reichman et al. 2014) (Table 2) .
Flow cytometry
Cells were detached with Accutase solution and harvested for quan-
titative analysis by ﬂow cytometry (Cytomics FC500 MCL; Beckman
Coulter) by staining the TRA-1-81, and SSEA-4 antibodies (Table 2)
and data were analyzed with FlowJo software.
Alkaline phosphatase and immunoﬂuorescence staining
Staining of ﬁxed hiPSCs was performed as described previously
(Reichman et al. 2014) (Table 2).Result Data
hESC-like morphology
Positive
Fig. 1, panel B
Expression of pluripotency markers: DNMT3B, LIN28A,
NANOG, NODAL, POU5F1, TERT, GDF3
Fig. 1, panel F
Expression of pluripotency markers: OCT4, NANOG,
SSEA4 and TRA1–60
Fig. 1, panels D and E
SSEA-4:97.8% and TRA1-81: 95.1% Supplementary Fig. 1A
46XX,
Resolution 450–500
Fig. 1, panel G
Genomic integrity Supplementary Fig. 1B
Genomic integrity and identity (parental ﬁbroblasts
and the respective iPS cell line)
Supplementary Fig. 1B
Heterozygous (GNA) Fig. 1, panel A
Mycoplasma testing by luminescence: Negative Supplementary Fig. 1C
Representation of all three germ layers formation Fig. 1, panel H
Table 2
Reagents details.
Antibodies used for immunocytochemistry/ﬂow cytometry
Antibody Dilution Company Cat # and RRID
OCT4 Rabbit mAb anti-OCT4 1:300 Cell Signaling Technology Cat#30A3, RRID:AB_2840
NANOG Rabbit mAb anti-NANOG 1:300 Cell Signaling Technology Cat#D73G4, RRID:AB_4903
SSEA4 Mouse mAb anti-SSEA4 1:300 Cell Signaling Technology Cat#MC813, RRID:AB_4755
TRA1–60 Mouse mAb anti-TRA1–60(S) 1:300 Cell Signaling Technology Cat#TRA-1-60(S), RRID:AB_4746
TRA1–81 PE- conjugated Mouse IgM anti Human TRA-1-81 1:50 R&D Systems Cat#TRA-1-81, RRID:AB_FAB8495P-025
SSEA4 APC-conjugated Mouse IgG3 anti Human/Mouse SSEA-4 1:50 R&D Systems Cat#MC-813-70, RRID:AB_FAB1435A-025
Secondary antibodies Alexa Fluor 594-conjugated Donkey anti-Rabbit IgG (H + L), 1:600 Thermo Fisher Scientiﬁc Cat# A-21207, RRID: AB_141637
Alexa Fluor 488-conjugated Donkey anti-Mouse IgG (H + L) 1:600 Thermo Fisher Scientiﬁc Cat# A-21202, RRID: AB_141607
Primers
Target Forward/Reverse primer (5′-3′)
Targeted mutation sequencing NR2E3 Exons2-3P4 GTGTGGATGCACAGTGAGG/CTGTTATAAGGCTGGCCATG
Elimination of Sendai virus transgenes (qPCR - TaqMan) SeV
SeV-OCT4
Sev-KLF4
Sev-SOX2
Sev-CMYC
Assay ID: Mr04269880_mr
Assay ID: Mr04269878_mr
Assay ID: Mr04269879_mr
Assay ID: Mr04269881_mr
Assay ID: Mr04269876_mr
Pluripotency markers (qPCR - TaqMan) DNMT3B
GDF3
LIN28
NANOG
NODAL
POU5F1 (OCT4)
TERT
Assay ID: DNMT3B-Hs00171876_m1
Assay ID: GDF3-Hs00220998_m1
Assay ID: LIN28A-Hs00702808_s1
Assay ID: NANOG-Hs02387400_g1
Assay ID: NODAL-Hs00415443_m1
Assay ID: POU5F1-Hs00999632_g1
Assay ID: TERT-Hs00972656_m1
House-keeping genes (qPCR - TaqMan) 18S Assay ID: 18S-Hs99999901_s1
4 A. Terray et al. / Stem Cell Research 24 (2017) 1–4Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2017.08.003.
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